The week in review


The #wanniwhitecoats @ the APP2017 Cabaret Street Party. Source: Twitter

We take a look back at the week in pharmacy

With the biggest event on the conference calendar, APP, finished over the weekend, it’s now time for Health Minister Greg Hunt to make good on the issues of risk share and 6CPA trial program funding, the Pharmacy Guild says. The Minister’s speech set a very positive tone to the beginning of the conference: but will he deliver? We’d like to know what you think, too. In the meantime, here’s what you had to say about APP17, here and on Twitter.

News out of Denmark revealed that the use of NSAIDs raises certain cardiac risk by 31%, and suggests that all drugs in this class should be pharmacist-only. Some AJP readers welcomed the study: “This data just reinforces that NSAIDs should be used in the lowest dose for the shortest duration if clinically indicated,” wrote Debbie Rigby. “And that pharmacists can help determine the least risky NSAID for an individual based on their medical history and cardiac/GI risk.”

ASMI says that most people will not be at risk, however, if they follow label instructions.

We learned that the Government has removed the ability for conscientious objectors to opt out of having their children vaccinated on the grounds of religion, if they still want to access family benefits. There was more news on the evolution of pharmacists’ roles. We got a peek at Pharmacy 777’s plans to bring the brand to pharmacies across Australia.

Thursday was also Close the Gap Day, and stakeholders spoke out about the importance of raising Aboriginal and Torres Strait Islanders’ health to the same level as non-Indigenous Australians.

Previous Faster access to new drugs doesn't always mean better treatment
Next Let’s talk about sex survey results

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.